Clinical Trial Update: Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating whether the fixed combination timolol maleate 0.5% / dorzolamide 2% provides additional intraocular pressure reduction when added to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Timolol maleate 0.5% / Dorzolamide 2% fixed combination (timolol maleate 0.5% / dorzolamide 2% fixed combination)

Snippet

Sponsor: University of Sao Paulo | Conditions: Glaucoma | Phase 4 | Status: COMPLETED